Genomic Profiling Study Brings Personalized Medicine to Metastatic Bladder Cancer Patients BETHESDA, Md., Sept. 24, 2015 (GLOBE NEWSWIRE) -- The Bladder Cancer Advocacy Network (BCAN) and Paradigm today announced a partnership for the launch of a large-scale genomically-driven bladder...

The Bladder Cancer Advocacy Network Invests $500,000 to Support Research BETHESDA, MD., June 9, 2015 (GLOBE NEWSWIRE) -- The Bladder Cancer Advocacy Network (BCAN) announces a $500,000 investment in research for 2015 demonstrating the organization's commitment to a bladder...